NCT06933836 DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
| NCT ID | NCT06933836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barnet Dulaney Perkins Eye Centers |
| Condition | Open Angle Glaucoma (OAG) |
| Study Type | OBSERVATIONAL |
| Enrollment | 55 participants |
| Start Date | 2025-03-31 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 55 participants in total. It began in 2025-03-31 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Eligibility Criteria
Inclusion Criteria: * Primary open angle glaucoma * Patients age 30 or greater with an IOP of 18-26 mmHg * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) * DSLT procedure Exclusion Criteria: * History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery * Angle closure patients * Ocular Hypertension * Baseline VF MD of worse than -12dB * Uncontrolled systemic microvascular disease (eg. HTN, DM) * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)
Contact & Investigator
Christine Funke, Medical Doctor
PRINCIPAL INVESTIGATOR
Barnet Dulaney Perkins Eye Centers
Frequently Asked Questions
Who can join the NCT06933836 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Open Angle Glaucoma (OAG). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06933836 currently recruiting?
Yes, NCT06933836 is actively recruiting participants. Contact the research team at derek.arnson@researchavp.com for enrollment information.
Where is the NCT06933836 trial being conducted?
This trial is being conducted at Mesa, United States.
Who is sponsoring the NCT06933836 clinical trial?
NCT06933836 is sponsored by Barnet Dulaney Perkins Eye Centers. The principal investigator is Christine Funke, Medical Doctor at Barnet Dulaney Perkins Eye Centers. The trial plans to enroll 55 participants.